Trials / Completed
CompletedNCT04871256
Effects of Septorhinoplasty on Allergic Rhinitis
Effects of Septorhinoplasty on Allergic Rhinitis Evolution
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 51 (actual)
- Sponsor
- Mario Pérez Sayáns · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
Allergic rhinitis (AR) is a chronic inflammatory disease that affects almost 30% of adult population. Some patients associate septal deviation, main cause of chronic nasal obstruction, and AR. Current literature about AR treatment with septoplasty (STP) is still contradictory, because is thought that patients with AR are not able to appreciate improvement after surgery. Patients diagnosed with allergic rinitis and septal deviation were evaluated to determined life quality and airflow obstruction evolution after STP.
Detailed description
This is a prospective quasi experimental study. After being informed about the study, patients that signed written informed consent were included in the study. In week 0 before surgery, all measurements and questionnaires were performed. 1 month after surgery, measurements were repeated. After screening, patient´s obstruction was evaluated by anterior rhinomanometry (RNMa), and quality of life scored through ESPRINT scale. ESPRINT is a validated Spanish questionnaire about daily life activity, sleep, psycology and perception of affection by allergic rhinitis. Symtoms were evaluated with visual analogue scale (VAS) and clinical history. Symptoms like sneezing, itchy nose, ocular symptoms and/or nasal obstruction. Also medication (intranasal corticosteroid, antileucotrienos, antihistamines eye drops , antishistamines) frequency use was registered.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Septorhinoplasty | This intervention will be performed by the same surgeon, after signing of patient inform consent. |
Timeline
- Start date
- 2021-01-01
- Primary completion
- 2021-03-01
- Completion
- 2021-03-01
- First posted
- 2021-05-04
- Last updated
- 2021-05-04
Locations
1 site across 1 country: Spain
Source: ClinicalTrials.gov record NCT04871256. Inclusion in this directory is not an endorsement.